Cited by 136Sperm and Testicular FunctionReproductive Biology and FertilityPharmacological Effects and Toxicity Studies

Reversible Toxic Effect of Salicylazosulf Apyridine on Semen Quality

Open access
Toth, Attila·1979·Fertility and Sterility

Abstract

The semen qualities of six patients with salicylazosulfapyridine-treated chronic ulcerative colitis are discussed. Over-all poor parameters were observed during the treatment period. Reduced motility and a shift in morphology were the most significant abnormalities in the specimens. A characteristic megalo cell type occurred in the morphology with a frequency of 3% to 8%. In three patients when no medical contraindication existed, discontinuation of the drug resulted in a dramatic improvement in the semen quality, and all three reported pregnancies within the ensuing 3 months. A possible reversible toxic effect of salicylazosulfapyridine on semen quality is discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0015-0282(16)44000-8

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Macrozoospermia may be of iatrogenic origin, as described after treatment with sulphasalazine for ulcerating colitis and Crohn's disease, and in this context the abnormality is reversible and may resolve when the treatment is changed.

    “Alternately, macrozoospermia may be of iatrogenic origin, as described after treatment with sulphasalazine for ulcerating colitis and Crohn's disease. In this context, the abnormality is reversible and may resolve when the treatment is changed [52, 53].”

    From Recommendations for Human Sperm Morphology Assessment in 2025: An Expert Review From the French BLEFCO Group (2026) · cites this paper as [52]

    The Abstract (page not specified) reports a characteristic megalo cell type during salicylazosulfapyridine treatment for chronic ulcerative colitis and dramatic improvement in overall semen quality after three patients stopped the drug. It does not study Crohn’s disease or establish that the megalo-cell abnormality itself resolved, rather than semen quality overall. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cited by

Sorted by citations

Authors
Toth, A.
Corresponding author
Toth, Attila
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
1979-05
Volume
31
Issue
5
Pages
538-540
ISSN
0015-0282 (ISSN-L)
OpenAlex
W2412758280
Cited by
136
References
0
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2020: 2 · 2018: 3 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 4 · 2013: 4 · 2012: 8
FWCI
6.48
Type
journal article
Language
en
Open access
Locations
  • Fertility and Sterility (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
Keywords
sulfasalazine, semen quality, ulcerative colitis, sperm motility, sperm morphology, drug discontinuation, reversible toxicity
MeSH terms
Colitis, Ulcerative, Humans, Infertility, Male, Male, Sulfasalazine, Semen, Sperm Motility, Spermatozoa

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review